1.Shlaes, DM, Gerding, DN, John, JF, et al. Society of Healthcare Epidemiology of America (SHEA) and Infectious Diseases Society of America (IDSA) Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18:275–291.
2.Fridkin, SK, Edwards, JR, Tenover, FC, Gaynes, R, McGowan, JE Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001;33:324–330.
3.Goldmann, DA, Weinstein, RA, Wenzel, RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234–240.
4.Peterson, LR, Hamilton, JD, Baron, EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001; 32:605–611.
5.National Committee For Clinical Laboratory Standards (NCCLS). Analysis and presentation of cumulative antimicrobial susceptibility test data: approved standard. NCCLS document M39-A. Wayne, PA: NCCLS; 2002.
6.Munson, EL, Diekema, DJ, Beekmann, SE, Chapin, KC, Doern, GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 2003; 41:495–497.
7.Ernst, EJ, Diekema, DJ, BootsMiller, BJ, et al. Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data? Diagn Microbiol Infect Dis 2004; 49:141–145.
8.Directory of Pathology Training Programs in the U.S. and Canada 2004-5. 36th ed. Bethesda, MD: Intersociety Committee on Pathology Information; 2003.
9.O'Brien, TF. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin Infect Dis 1997; 24(Suppl 1):S2–S8.
10.Bryce, EA, Smith, JA. Focused microbiological surveillance and gram-negative beta-lactamase–mediated resistance in an intensive care unit. Infect Control Hosp Epidemiol 1995; 16:331–334.
11.Kaufman, D, Haas, CE, Edinger, R, Hollick, G. Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogram. Arch Surg 1998; 133:1041–1045.
12.Leibovici, L, Shraga, I, Drucker, M, Konigsberger, H, Samra, Z, Pitlik, SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379–386.
13.Ibrahim, EH, Sherman, G, Ward, S, Fraser, VJ, Kollef, MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146–155.
14.Harbarth, S, Garbino, J, Pugin, J, Romand, JA, Lew, D, Pittet, D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529–535.
15.Boyce, JM. Are the epidemiology and microbiology of methicillin-resis-tant Staphylococcus aureus changing? JAMA 1998; 279:623–624.
16.Stevenson, KB, Samore, M, Barbera, J, et al. Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards. Diagn Microbiol Infect Ds 2003; 47:303–311.